Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats

被引:57
|
作者
Chagas, Marcos Hortes N. [1 ]
Crippa, Jose Alexandre S. [1 ]
Zuardi, Antonio Waldo [1 ]
Hallak, Jaime E. C. [1 ]
Machado-de-Sousa, Joao Paulo [1 ]
Hirotsu, Camila [2 ]
Maia, Lucas [2 ]
Tufik, Sergio [2 ]
Andersen, Monica Levy [2 ]
机构
[1] Univ Sao Paulo, Dept Neurosci & Behav, Ribeirao Preto Med Sch, INCT Translat Med CNPq, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo UNIFESP, Dept Psychobiol, Sao Paulo, Brazil
关键词
Cannabidiol; sleep; sleep-wake cycle; MODULATES SLEEP; DOPAMINE LEVELS; ANXIETY; MODEL; ANTAGONIST; DRUG; CB1;
D O I
10.1177/0269881112474524
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cannabidiol (CBD) is one of the main components of Cannabis sativa and has a wide spectrum of action, including effects in the sleep-wake cycle. Objective: The objective of this paper is to assess the effects on sleep of acute systemic administration of CBD. Method: Adult male Wistar rats were randomly distributed into four groups that received intraperitoneal injections of CBD 2.5 mg/kg, CBD 10 mg/kg, CBD 40 mg/kg or vehicle (n=seven animals/group). Sleep recordings were made during light and dark periods for four days: two days of baseline recording, one day of drug administration (test), and one day after drug (post-test). Results: During the light period of the test day, the total percentage of sleep significantly increased in the groups treated with 10 and 40 mg/kg of CBD compared to placebo. REM sleep latency increased in the group injected with CBD 40 mg/kg and was significantly decreased with the dose of 10 mg/kg on the post-test day. There was an increase in the time of SWS in the group treated with CBD 40 mg/kg, although this result did not reach statistical significance. Conclusion: The systemic acute administration of CBD appears to increase total sleep time, in addition to increasing sleep latency in the light period of the day of administration.
引用
收藏
页码:312 / 316
页数:5
相关论文
共 50 条
  • [11] Effects of valerian extract on the sleep-wake cycle in sleep-disturbed rats
    Shinomiya, K
    Fujimura, K
    Kim, Y
    Kamei, C
    ACTA MEDICA OKAYAMA, 2005, 59 (03) : 89 - 92
  • [12] EFFECT OF VINPOCETINE ON THE SLEEP-WAKE CYCLE OF RATS
    SARKADI, A
    LASZY, J
    SZPORNY, L
    DRUG DEVELOPMENT RESEARCH, 1988, 14 (3-4) : 335 - 341
  • [13] Effects of some drugs on sleep-wake cycle in depression model induced by chronic administration of ACTH in rats
    Tsutsui, Ryuki
    Ishida, Takayuki
    Suga, Asami
    Obara, Yoshihito
    Kamei, Chiaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 106P - 106P
  • [14] Effects of benzodiazepine hypnotics and antihistamines on the sleep-wake cycle in sleep-disturbed rats
    Tokunaga, S
    Shinomiya, K
    Ohmori, A
    Takeda, Y
    Hirase, M
    Fujii, Y
    Kamei, C
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 140P - 140P
  • [15] EFFECTS OF DIPROPYLACETATE ON SLEEP-WAKE CYCLE IN INFANTS
    PATY, J
    DEMARQUEZ, JL
    DELIAC, MM
    BRACHETLIERMAIN, M
    FABRE, JMA
    MARTIN, C
    ARCHIVES FRANCAISES DE PEDIATRIE, 1978, 35 (03): : 335 - 336
  • [16] EFFECTS OF ACUTE KYNURENINE CHALLENGE ON SLEEP-WAKE ARCHITECTURE IN MALE RATS
    Pocivavsek, A.
    Baratta, A. M.
    Viechweg, S. S.
    Mong, J. A.
    SLEEP, 2017, 40 : A40 - A40
  • [17] EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH AMITRYPTYLINE ON THE SLEEP-WAKE ACTIVITY OF RATS
    OBAL, F
    BENEDEK, G
    LELKES, Z
    OBAL, F
    NEUROPHARMACOLOGY, 1985, 24 (03) : 223 - 229
  • [18] EFFECTS OF VARIOUS PROTEIN-SYNTHESIS INHIBITORS ON SLEEP-WAKE CYCLE OF RATS
    ROJASRAMIREZ, JA
    AGUILARJIMENEZ, E
    POSADASANDREWS, A
    BERNALPEDRAZA, JG
    DRUCKERCOLIN, RR
    PSYCHOPHARMACOLOGY, 1977, 53 (02) : 147 - 150
  • [19] Melatonin and the sleep-wake cycle
    Kunz, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S597 - S597
  • [20] Effects of kava-kava extract on the sleep-wake cycle in sleep-disturbed rats
    Shinomiya, K
    Inoue, T
    Utsu, Y
    Tokunaga, S
    Masuoka, T
    Ohmori, A
    Kamei, C
    PSYCHOPHARMACOLOGY, 2005, 180 (03) : 564 - 569